The European Medicines Agency (EMA) has approved Moleculin Biotech’s clinical trial application (CTA) for a pivotal, ...

Thoughts of suicide was confirmed as a side effect of finasteride (Propecia, Proscar), the European Medicines Agency (EMA) ...

New figures from European industry group EFPIA paint a stark picture of the growing divide in access to innovative medicines ...

The European drugs regulator said on Thursday its safety panel has confirmed suicidal thoughts as a side effect of ...

On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin” or the "Company”), a late-stage pharmaceutical company with a broad ...

The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...

Few areas of healthcare are as sensitive as cancer treatment. Each year, around 44,000 cancer tumours are diagnosed here.

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...

Aurobindo Pharma's CuraTeQ Biologics receives marketing authorization for Zefylti filgrastim biosimilar in the UK and EU.

The drug receives conditional marketing authorization by the CHMP for the treatment of HER2-positive biliary tract cancer.

Saint Herblain (France), May, 07 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) has started a review ...